help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on April 2, 2009, doi:10.1164/rccm.200901-0047OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200901-0047OCv1
180/1/3    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kohansal, R.
Right arrow Articles by Soriano, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kohansal, R.
Right arrow Articles by Soriano, J. B.
American Journal of Respiratory and Critical Care Medicine Vol 180. pp. 3-10, (2009)
© 2009 American Thoracic Society
doi: 10.1164/rccm.200901-0047OC


Original Article

The Natural History of Chronic Airflow Obstruction Revisited

An Analysis of the Framingham Offspring Cohort

Robab Kohansal1,2, Pablo Martinez-Camblor1,3, Alvar Agustí1,4,5, A. Sonia Buist6, David M. Mannino7 and Joan B. Soriano1,4

1 Program of Epidemiology and Clinical Research, Fundación Caubet-CIMERA Illes Balears, International Centre for Advanced Respiratory Medicine, Bunyola, Illes Balears, Spain; 2 Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for COPD, Vienna, Austria; 3 Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBEResp), Subdirección de Salud Pública de Gipuzkoa, Donostia, Spain; 4 Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERes), Spain; 5 Pneumology Department, Hospital Universitari Son Dureta, Palma de Mallorca, Illes Balears, Spain; 6 Pulmonary and Critical Care Medicine, Oregon Health and Science University, Portland, Oregon; and 7 Department of Preventive Medicine and Environmental Health, University of Kentucky College of Public Health, Lexington, Kentucky

Correspondence and requests for reprints should be addressed to Joan B. Soriano, M.D., Epidemiology and Clinical Research, Fundación Caubet-CIMERA Illes Balears, Carretera Soller km 12, Recinte Hospital Joan March, 07110-Bunyola, Illes Balears, Spain. E-mail: jbsoriano{at}caubet-cimera.es

Rationale: Understanding normal lung development and aging in health and disease, both in men and in women, is essential to interpreting any therapeutic intervention.

Objectives: We aimed to describe lung function changes in healthy never-smoking males and females, from adolescence to old age, and to determine the effects of smoking and those derived from quitting.

Methods: Prospective cohort study within all participants of the Framingham Offspring cohort who had two or more valid spirometry measurements during follow-up (n = 4,391; age range at baseline 13 to 71 yr), with a median follow-up time of 23 years.

Measurements and Main Results: To best fit the curves describing FEV1 changes with age to raw data, we used a generalized additive model with smooth terms and incorporating the subject-specific (longitudinal) random effects. We found that: (1) healthy never-smoker females achieve full lung growth earlier than males, and their rate of decline with age was slightly, but not significantly, lower; (2) smoking increases the rate of lung function decline, both in males and in females; (3) there is a range of susceptibility to the effects of smoking. The presence of respiratory symptoms at baseline and/or a respiratory diagnosis during follow-up appears to identify a group of susceptible smokers; and (4) quitting smoking has a beneficial effect at any age, but it is more pronounced in earlier quitters.

Conclusions: Lung function changes from adolescence to old age differ in males and females, smoking has similar deleterious effects in both sexes, and quitting earlier is better.

Key Words: chronic obstructive pulmonary disease • FEV1 • sex • lung function • natural history


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Determining lung function development, both in health and in disease, remains an important issue, especially to interpret new strategies and drugs targeted to modify the natural history of chronic obstructive pulmonary disease.

What This Study Adds to the Field
Lung function changes from adolescence to old age differ in males and females, smoking has similar deleterious effects in both sexes, and quitting earlier is better.

 



This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
R. A. Maciewicz, D. Warburton, and S. I. Rennard
Can Increased Understanding of the Role of Lung Development and Aging Drive New Advances in Chronic Obstructive Pulmonary Disease?
Proceedings of the ATS, December 1, 2009; 6(7): 614 - 617.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. G. Camp, D. E. O'Donnell, and D. S. Postma
Chronic Obstructive Pulmonary Disease in Men and Women: Myths and Reality
Proceedings of the ATS, September 15, 2009; 6(6): 535 - 538.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2009 American Thoracic Society
  New Orleans Int'l Conf